Trials / Terminated
TerminatedNCT00185523
Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)
Allogeneic Peripheral Blood Stem Cell Transplantation for Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia in First or Second Remission or Chronic Myelogenous Leukemia in First and Second Chronic Phase or Accelerated Phase
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 88 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 4 Weeks – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the overall and disease free survival of recipients who have received G-CSF mobilized stem cells from HLA matched sibling donors.
Detailed description
Allogeneic Peripheral Blood Stem Cell Transplantation for Patients with Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia in First Remission or Chronic Myelogenous Leukemia in First Chronic Phase
Conditions
- Leukemia, Lymphocytic, Acute
- Leukemia
- Leukemia Acute Promyelocytic Leukemia (APL)
- Leukemia Acute Lymphoid Leukemia (ALL)
- Leukemia Chronic Myelogenous Leukemia (CML)
- Leukemia Acute Myeloid Leukemia (AML)
- Leukemia Chronic Lymphocytic Leukemia (CLL)
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Allogeneic hematopoietic cell transplantation |
Timeline
- Start date
- 2002-05-01
- Primary completion
- 2009-04-01
- Completion
- 2009-04-01
- First posted
- 2005-09-16
- Last updated
- 2016-06-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00185523. Inclusion in this directory is not an endorsement.